Alqurashi W, Stiell I, Chan K, et al. Epidemiology and clinical predictors of biphasic reactions in children with anaphylaxis. Ann Allergy Asthma Immunol. 2015;115(3):217-223.e2. doi:10.1016/j.anai.2015.06.018
Food Allergy Canada, Canadian Society of Allergy and Clinical Immunology. National Food Allergy Action Plan. Published July 2019.
Gabrielli S, Clarke A, Morris J, et al. Evaluation of prehospital management in a Canadian emergency department anaphylaxis cohort. J Allergy Clin Immunol Pract. 2019;7(7):2232-2238.e3. doi:10.1016/j.jaip.2019.04.018
Worm M, Francuzik W, Renaudin J-M, et al. Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European Anaphylaxis Registry. Allergy. 2018;73(6):1322-1330. doi:10.1111/all.13380
Alqurashi W, Ellis AK. Do corticosteroids prevent biphasic anaphylaxis?. J Allergy Clin Immunol Pract. 2017;5(5):1194-1205. doi:10.1016/j.jaip.2017.05.022
Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472. doi:10.1016/j.waojou.2020.100472
Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis – a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082-1123. doi:10.1016/j.jaci.2020.01.017
Alqurashi W, Awadia A, Pouliot A, et al. The Canadian anaphylaxis action plan for kids: development and validation. Patient Educ Couns. 2020;103(1):227-233. doi:10.1016/j.pec.2019.07.028
Halbrich M, Mack DP, Carr S, Watson W, Kim H. CSACI position statement: epinephrine auto-injectors and children <15 kg. Allergy Asthma Clin Immunol. 2015;11(1):20. doi:10.1186/s13223-015-0090-8

Pour la liste complète des données probantes qui ont informé l’élaboration des Recommandations de base sur l’anaphylaxie, voir le Référentiel médical.

Pour en savoir plus sur le processus de développement, voir notre site web.